Table 2 Pairwise comparisons of mean global quality of life score (QL2) between groups over time.

From: Effects of rice bran arabinoxylan compound on quality of life of cancer patients during active treatment: a randomised placebo-controlled pilot trial

Visit

Variable (unit)

RBAC

Placebo

p-value

Cohen’s d

0 (Baseline)

QL2 (1–100)

70.8 ± 21.6

60.0 ± 19.0

0.156

0.533

1 (Week 6)

QL2 (1–100)

75.8 ± 14.4

57.6 ± 17.9

0.017*

1.118

2 (Week 12)

QL2 (1–100)

73.1 ± 14.9

66.7 ± 13.4

0.315

0.457

3 (Week 18)

QL2 (1–100)

70.4 ± 12.6

63.89 ± 19.5

0.486

0.394

4 (Week 24)

QL2 (1–100)

79.2 ± 19.7

57.41 ± 24.8

0.041*

0.971

  1. Significant values are in bold.
  2. ^Statistically significant difference between two means based on the two-sided Student’s t-test with p ≤ 0.05 (with multiplicity adjusted with false discovery rate). RBAC = rice bran arabinoxylan compound.
Back to article page